Cargando…
Computational strategy for intrinsically disordered protein ligand design leads to the discovery of p53 transactivation domain I binding compounds that activate the p53 pathway
Intrinsically disordered proteins or intrinsically disordered regions (IDPs) have gained much attention in recent years due to their vital roles in biology and prevalence in various human diseases. Although IDPs are perceived as attractive therapeutic targets, rational drug design targeting IDPs rem...
Autores principales: | Ruan, Hao, Yu, Chen, Niu, Xiaogang, Zhang, Weilin, Liu, Hanzhong, Chen, Limin, Xiong, Ruoyao, Sun, Qi, Jin, Changwen, Liu, Ying, Lai, Luhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179352/ https://www.ncbi.nlm.nih.gov/pubmed/34164069 http://dx.doi.org/10.1039/d0sc04670a |
Ejemplares similares
-
Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
por: Miyamoto, Takafumi, et al.
Publicado: (2017) -
Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations
por: Liu, Xiaorong, et al.
Publicado: (2020) -
Regression based predictor for p53 transactivation
por: Gowrisankar, Sivakumar, et al.
Publicado: (2009) -
DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
por: Chen, Ling, et al.
Publicado: (2019) -
D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)